Insmed (INSM) PT Lowered to $212 at Mizuho, 'We're Buyers on Weakness'
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh lowered the price target on Insmed (NASDAQ: INSM) to $212.00 (from $256.00) while maintaining a Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
